Denali Therapeutics Inc. stock price ended on $32.36 on Friday after losing 1.46%
(Updated on Jan 21, 2022)
Sell candidate since 2022-01-04 Loss -29.16% PDF
The Denali Therapeutics Inc. stock price fell by -1.46% on the last day (Friday, 21st Jan 2022) from $32.84 to $32.36. and has now fallen 3 days in a row. During the day the stock fluctuated 6.79% from a day low at $32.24 to a day high of $34.43. The price has fallen in 7 of the last 10 days and is down by -26.39% for this period. Volume has increased on the last day by 172 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 649 thousand shares were bought and sold for approximately $21.02 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $30.75 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.86% during the next 3 months and, with a 90% probability hold a price between $23.41 and $33.77 at the end of this 3-month period.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, January 18, 2022, and so far it has risen 2.99%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Denali Therapeutics Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $33.86 and $42.48. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss
Denali Therapeutics Inc. finds support from accumulated volume at $31.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $2.19 between high and low, or 6.79%. For the last week, the stock has had a daily average volatility of 7.54%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Denali Therapeutics Inc. stock A Buy?
Denali Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -4.236Sell Candidate Unchanged
Insiders are positive buying more shares than they are selling in Denali Therapeutics Inc.
In the last 100 trades there were 872.25 thousand shares bought and 750.6 thousand shares sold. The last trade was done 14 days ago by Thornberry Nancy who bough 627 shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside. In some cases larger purchases can be explained by due date for stock options.
Predicted Opening Price for Denali Therapeutics Inc. of Monday, January 24, 2022
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price January 24, 2022||Current price|
Remember To Visit Our YouTube Channel
On Jan 06, 2022 "Morgan Stanley" gave "$99.00 - $91.00" rating for DNLI. The price target was changed from $43.96 to 1.3%.
DNLI Insider Trading
|Jan 08, 2022||Buy||627||Thornberry Nancy||Common Stock|
|Jan 05, 2022||Sell||2 846||Schuth Alexander O.||Common Stock|
|Jan 05, 2022||Sell||2 845||Ho Carole||Common Stock|
|Jan 05, 2022||Sell||2 225||Krognes Steve E.||Common Stock|
|Jan 05, 2022||Sell||5 007||Watts Ryan J.||Common Stock|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.